🕵️ Rezolute, Inc. ($RZLT)
SEC insider & ownership activity, last 12 months · CIK 1509261 · every row links its SEC filing
Over the last 12 months insiders bought $236K with no open-market selling against it. Evans Daron bought $108K (Dec–Mar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
5 buyers, $236K (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Evans Daron | 4 | $108K | 0 | – | Mar 30, 2026 |
| Nevan C. Elam | 1 | $51K | 0 | – | Dec 15, 2025 |
| Roberts Brian Kenneth | 1 | $48K | 0 | – | Dec 16, 2025 |
| Karnawat Sunil Ratilal | 2 | $20K | 0 | – | Dec 15, 2025 |
| Hogenhuis Wladimir | 1 | $10K | 0 | – | Dec 16, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 9.9% | 13G | Dec 18, 2025 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | Dec 18, 2025 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | Dec 18, 2025 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | Dec 18, 2025 | filing ↗ | |
| Opaleye Management Inc. | 6.6% | 13G | May 11, 2026 | filing ↗ | |
| James Silverman | 6.6% | 13G | May 11, 2026 | filing ↗ | |
| Bank of America Corp /DE/ | 6.5% | 13G | Feb 11, 2026 | filing ↗ | |
| Opaleye, L.P. | 6.4% | 13G | May 11, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.4% | 13G | Oct 17, 2025 | filing ↗ | |
| Balyasny Asset Management L.P. | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| BAM GP LLC | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| Balyasny Asset Management Holdings LP | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| Dames GP LLC | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| Dmitry Balyasny | 5.3% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 17, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 17, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 17, 2025 | filing ↗ |
| Earnings (2.02) | Sep 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing ↗ |